In conclusion, our substantial body of work focusing on the NSUN2/YBX1/m5C‐ENO1 signaling axis may offer valuable insights pertaining to the pathogenesis and identification of epigenetic–immune targets in CRC. Here, ENO1 is linked to colorectal carcinoma.